NFKB1 and cancer: Moench.[85] Studies have proven that CA has various pharmacological activities such as anti-inflammatory, antioxidant, antibacterial, and immune enhancement.[86,87] Finally, the expression of NF-κB-related proteins and their downstream inflammatory factors significantly decreased after CA treatment.[88] This shows that CA is also a new therapeutic strategy to treat GA by regulating the NF-κB signaling pathway.